CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
Phonak Audeo hearing aiddevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05150964
NCT05150964N/ACompleted
CompareCT.gov

Measuring Comfort and Clarity Using Low Gain Feature in Pediatric Hearing Aid Users

Sonova AG·interventional·Posted Dec 9, 2021·Updated May 19, 2023

In Brief

A clinical study evaluating Phonak Audeo hearing aid for Hearing Loss. Completed, enrolled 16 participants across 1 site.

Detailed Summary

Comfort and clarity of speech will be measured in hearing impaired children age 8-17 using standard speech processing algorithm with a soft speech enhancer feature, referred to as the Adaptive Situational Gain (ASG) feature in study documents.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesUnited States
CollaboratorsArizona State University

Timeline

N/ACompletedFinished
20222023202420252026
First PostedDec 9, 2021
Enrollment StartJun 1, 2021
Primary CompletionOct 15, 2021
Study CompletionMay 29, 2022
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.6 years ago

Interventions

Phonak Audeo hearing aiddevice

receiver in the canal devices with custom earmolds